NEU:ASX
Neuren Pharmaceuticals Ltd
A$20.13
arrow_downward
-0.35%(-0.070) 1D
Oct 7, 4:10:07 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$20.10
High
A$20.39
Low
A$19.96
Mkt. cap
2.55B
Avg. vol.
429.50K
Volume
305.00K
Dividend
0.75%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
130.40
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$20.10
High
A$20.39
Low
A$19.96
Mkt. cap
2.55B
Avg. vol.
429.50K
Volume
305.00K
Dividend
0.75%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
130.40
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
Simply Wall Street
·
5 minutes ago
Neurocrine Biosciences (NBIX) After New VYKAT XR Data Why The Undervalued Narrative Persists
Yahoo Finance
·
1 hour ago
S&P 500, Nasdaq hit records — but 'the breadth of the rally has narrowed': Chart of the Day
The Motley Fool
·
11 minutes ago
Is the S&P 500 Historically Expensive or Cheap? The Answer Depends on How You Look at It.
Reuters
·
27 minutes ago
COMMENTARY: Morning Bid: Storm brewing
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com